It was a good call, but I think it is wiser to buy this company now at 88c, than then at 42c, as much clinical trial risk is removed.
Some few years ahead for this company, imho.
- Forums
- ASX - By Stock
- PEP
- peplin granted us patent for anti-cancer compounds
peplin granted us patent for anti-cancer compounds, page-3
Featured News
Add PEP (ASX) to my watchlist
|
|||||
Last
$3.69 |
Change
0.000(0.00%) |
Mkt cap ! $680.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |